Deletion of adenosine A₁ or A(₂A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease
about
Coffee, Genetic Variants, and Parkinson's Disease: Gene-Environment InteractionsDrug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?Caffeine: cognitive and physical performance enhancer or psychoactive drug?Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson's disease patientsAdenosine hypothesis of schizophrenia--opportunities for pharmacotherapyUsing caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.Extracellular nucleotide and nucleoside signaling in vascular and blood diseasePreclinical jockeying on the translational track of adenosine A2A receptors.Caffeine consumption and risk of dyskinesia in CALM-PD.The emerging role of nutrition in Parkinson's disease.Label-Free Neuroproteomics of the Hippocampal-Accumbal Circuit Reveals Deficits in Neurotransmitter and Neuropeptide Signaling in Mice Lacking Ethanol-Sensitive Adenosine TransporterExercise and Nutritional Benefits in PD: Rodent Models and Clinical Settings.Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors.Overexpression of GRK6 rescues L-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats.Adenosine A1 receptors measured with 11 C-MPDX PET in early Parkinson's disease.A Meta-Analysis of Adenosine A2A Receptor Antagonists on Levodopa-Induced Dyskinesia In Vivo.Caffeine Protects Dopaminergic Neurons From Dopamine-Induced Neurodegeneration via Synergistic Adenosine-Dopamine D2-Like Receptor Interactions in Transgenic Caenorhabditis elegans.
P2860
Q26852456-39080E80-97ED-498A-BD55-92A49ACAEF33Q27021464-23636CB2-2FA2-42A4-9147-ADBBED4A5F9BQ28080581-1C73758E-4D61-43D0-907A-3E1183F2A553Q28477288-DE8BC64F-F03B-4781-A1DB-F83F81B34C54Q30457808-A51924AC-CCC7-43E5-A723-2454F78DEA2CQ33971113-3ABF7C81-FD8E-4EDC-834D-933888FEAFCDQ34047834-A7CF1E9E-CE69-4E02-9475-D375D34F53D5Q34777609-733C971C-4BB5-4C11-B9ED-1C7D78FBBB83Q36717838-B1E4EB48-7CD5-44BC-8F3D-6E1605DEBC1DQ37622710-DCB1F422-DD4D-4906-A0EE-840D3B92AF23Q37742174-0AC96948-8CF2-444F-A7F9-0D039C6BF40CQ38686112-33ED66E1-3AAD-4B46-A8E4-ABB456B178B9Q41649807-A61613AA-1B5A-45D9-805B-604340CFC355Q42512289-9B627340-3B32-4C00-A9B2-5FE767255ABEQ48277907-F3668BCC-894C-4E77-A313-F3265DA8838FQ49452726-72C87DD0-AC1D-4009-9CCA-B7FD19175D0BQ54975826-62AB70D2-E583-4794-BC34-592F4EF91594
P2860
Deletion of adenosine A₁ or A(₂A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Deletion of adenosine A₁ or A( ...... a model of Parkinson's disease
@ast
Deletion of adenosine A₁ or A( ...... a model of Parkinson's disease
@en
Deletion of adenosine A₁ or A( ...... a model of Parkinson's disease
@nl
type
label
Deletion of adenosine A₁ or A( ...... a model of Parkinson's disease
@ast
Deletion of adenosine A₁ or A( ...... a model of Parkinson's disease
@en
Deletion of adenosine A₁ or A( ...... a model of Parkinson's disease
@nl
prefLabel
Deletion of adenosine A₁ or A( ...... a model of Parkinson's disease
@ast
Deletion of adenosine A₁ or A( ...... a model of Parkinson's disease
@en
Deletion of adenosine A₁ or A( ...... a model of Parkinson's disease
@nl
P2093
P2860
P1433
P1476
Deletion of adenosine A₁ or A( ...... a model of Parkinson's disease
@en
P2093
Bertil B Fredholm
Brian Healy
Danqing Xiao
Jared J Cassin
Jiang-Fan Chen
Thomas C Burdett
P2860
P304
P356
10.1016/J.BRAINRES.2010.08.099
P407
P577
2010-09-07T00:00:00Z